These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6446634)

  • 61. Role of 5-hydroxytryptamine in the modulation of acoustic brainstem (far-field) potentials.
    Bhargava VK; McKean CM
    Neuropharmacology; 1977 Jun; 16(6):447-9. PubMed ID: 143622
    [No Abstract]   [Full Text] [Related]  

  • 62. Modulation of luteinizing hormone release and catecholamine activity by opiates in the female rat.
    Adler BA; Crowley WR
    Neuroendocrinology; 1984 Mar; 38(3):248-53. PubMed ID: 6717750
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Central action of narcotic analgesics. V. Participation of serotonin in the mechanism of action of narcotic analgesics.
    Fidecka S; Langwiński R
    Pol J Pharmacol Pharm; 1979; 31(5):461-71. PubMed ID: 44745
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Counteraction of gonadal steroid inhibition of luteinizing hormone release by naloxone.
    Van Vugt DA; Sylvester PW; Aylsworth CF; Meites J
    Neuroendocrinology; 1982 Apr; 34(4):274-8. PubMed ID: 7041002
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The brain serotonergic system in the affective disorders.
    Murphy DL; Campbell IC; Costa JL
    Prog Neuropsychopharmacol; 1978; 2(1):5-31. PubMed ID: 214806
    [No Abstract]   [Full Text] [Related]  

  • 66. Central action of narcotic analgesics. VI. Further studies on the participation of serotonin in the action of analgesics.
    Malec D
    Pol J Pharmacol Pharm; 1980; 32(5):665-72. PubMed ID: 6115369
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of morphine and naloxone on inhibition by ovarian hormones of pulsatile release of LH in ovariectomized rats.
    Sylvester PW; Van Vugt DA; Aylsworth CA; Hanson EA; Meites J
    Neuroendocrinology; 1982 Apr; 34(4):269-73. PubMed ID: 6122171
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Serotonergic excitation from dorsal raphe stimulation recorded intracellularly from rat caudate-putamen.
    Park MR; Gonzales-Vegas JA; Kitai ST
    Brain Res; 1982 Jul; 243(1):49-58. PubMed ID: 6214298
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Morphine administration in the amygdala or periaqueductal central gray depress serum levels of luteinizing hormone.
    Lakoski JM; Gebhart GF
    Brain Res; 1982 Jan; 232(1):231-7. PubMed ID: 7055705
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A biochemical--behavioral model for studying serotonergic supersensitivity in brain.
    Fleisher LN; Simon JR; Aprison MH
    J Neurochem; 1979 Jun; 32(6):1613-9. PubMed ID: 156246
    [No Abstract]   [Full Text] [Related]  

  • 71. Role of sexual differentiation of the hypothalamus in the differential effect of the serotoninergic system on LH in prepubertal male and female rats.
    Moguilevsky JA; Faigón MR; Scacchi P; Szwarcfarb B
    Neuroendocrinology; 1987 Apr; 45(4):274-7. PubMed ID: 3494959
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Quasi morphine-abstinence syndrome.
    Collier HO; Francis DL; Henderson G; Schneider C
    Nature; 1974 May; 249(456):471-3. PubMed ID: 4545823
    [No Abstract]   [Full Text] [Related]  

  • 73. Naloxone-induced increases in serum luteinizing hormone in the male: mechanisms of action.
    Cicero TJ; Wilcox CE; Bell RD; Meyer ER
    J Pharmacol Exp Ther; 1980 Mar; 212(3):573-8. PubMed ID: 6244390
    [No Abstract]   [Full Text] [Related]  

  • 74. Endogenous opioids participate in the regulation of the hypothalamus-pituitary-luteinizing hormone axis and testosterone's negative feedback control of luteinizing hormone.
    Cicero TJ; Schainker BA; Meyer ER
    Endocrinology; 1979 May; 104(5):1286-91. PubMed ID: 374068
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Serotonin of somnotonin?].
    Koella WP
    Schweiz Med Wochenschr; 1970 Feb; 100(8):357-64 contd. PubMed ID: 4401183
    [No Abstract]   [Full Text] [Related]  

  • 76. Evidence for endogenous opioid modulation of serum luteinizing hormone and prolactin in the steer.
    Peck DD; Thompson FN; Stuedemann JA; Leshin LS; Kiser TE
    J Anim Sci; 1988 Dec; 66(12):3197-201. PubMed ID: 3230079
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Naloxone stimulation of in vivo LHRH release is not diminished following ovariectomy.
    Karahalios DG; Levine JE
    Neuroendocrinology; 1988 Jun; 47(6):504-10. PubMed ID: 3135508
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Missing indicator function of growth hormone and luteinizing hormone blood levels for dopamine and serotonin concentration in the human brain.
    Benkert O; Laakmann G; Souvatzoglou A; von Werder K
    J Neural Transm; 1973; 34(4):291-9. PubMed ID: 4544120
    [No Abstract]   [Full Text] [Related]  

  • 79. Cyclic changes in cortical excitability in waking rats during induced changes in serotonin and noradrenalin metabolism.
    Gromova EA; Vorob'ev VV
    Neurosci Behav Physiol; 1979; 9(4):383-7. PubMed ID: 158715
    [No Abstract]   [Full Text] [Related]  

  • 80. Inhibition of naloxone of prolactin release induced by L-5-hydroxytryptophan in rats.
    Matsushita N; Kato Y; Katakami H; Shimatsu A; Imura H
    Proc Soc Exp Biol Med; 1981 Nov; 168(2):282-5. PubMed ID: 6983076
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.